Wellnex Life Ltd (ASX: WNX) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Wellnex Life Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $31.85 million
P/E Ratio N/A
Dividend Yield N/A
Shares Outstanding 303.31 million
Earnings per share -0.045
Dividend per share N/A
Year To Date Return -3.09%
Earnings Yield N/A
Franking N/A
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

Should you invest $1,000 in right now?

Before you consider , you’ll want to hear this.

Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and wasn’t one of them.

The online investing service he’s run for nearly a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.

*Returns as of August 16th 2021

Wellnex Life Ltd (ASX: WNX)
Latest News

group of friends jump on the beach
Share Market News

Here’s why the Wellnex Life (ASX:WNX) share price jumped 37% today

It's been an interesting couple of days for this rebranded health and wellness company

Read more »

falling asx share price represented by woman making sad face
Share Fallers

Why the Wellnex Life (ASX:WNX) share price is crashing 75% lower on Thursday

Wattle Health is back as Wellnex Life...

Read more »

money loading, invest, boost earnings
Capital Raising

ASX infant formula group Wattle Health to raise $39.7 million in new shares

ASX infant formula company Wattle Health Australia (ASX: WHA) is looking to raise $39.7 million in new shares in the…

Read more »

A2 Baby formula shares
⏸️ Growth Investing

Can ASX infant formula shares soar in 2020?

The ASX infant formula shares have been climbing higher in recent years, but what will a new decade mean for…

Read more »

thumbs down
Share Market News

Infant formula company Wattle Health to remain suspended after failed rights issue

The Wattle Health Australia Limited (ASX:WHA) share price will remain suspended for the foreseeable future after failing to raise money…

Read more »

baby formula shares
Share Market News

Wattle Health announces deal with Chemist Warehouse

This morning Wattle Health Australia Limited (ASX:WHA) announced a deal with retail giant Chemist Warehouse...

Read more »

Share Market News

Wattle Health announces new China-based joint venture

Wattle Health Australia Limited (ASX:WHA) has announced a new joint venture in China. Here's what you need to know...

Read more »

Share Fallers

Why Clinuvel, Newcrest, Starpharma, & Wattle Health shares dropped lower

The Clinuvel Pharmaceuticals Limited (ASX:CUV) share price and the Wattle Health Australia Ltd (ASX:WHA) share price are two of four ending the week…

Read more »

WNX ASX Announcements

An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
YesNo

About Wellnex Life Ltd

Wellnex Life Ltd is engaged in developing health and wellness products. It offers products including nutritional food products, natural baby skincare range, and nutritional health supplement range.

WNX Share Price History Data provided by Morningstar.

Data provided by Morningstar.
Date Close Change % Change Volume Open High Low
17 May 2022 $0.11 $0.01 10.64% 983,312 $0.10 $0.11 $0.10
16 May 2022 $0.09 $0.00 0.00% 243,312 $0.10 $0.10 $0.09
13 May 2022 $0.10 $0.00 0.00% 53,817 $0.10 $0.10 $0.09
12 May 2022 $0.10 $0.00 0.00% 622,483 $0.10 $0.10 $0.09
11 May 2022 $0.10 $0.00 0.00% 10,628 $0.10 $0.10 $0.10
10 May 2022 $0.10 $0.00 0.00% 581,963 $0.10 $0.10 $0.10
09 May 2022 $0.10 $0.00 0.00% 361,999 $0.10 $0.10 $0.10
06 May 2022 $0.10 $0.00 0.00% 30,139 $0.10 $0.10 $0.10
05 May 2022 $0.10 $0.00 0.00% 14,250 $0.10 $0.10 $0.10
04 May 2022 $0.10 $0.00 0.00% 15,940 $0.10 $0.10 $0.10
03 May 2022 $0.10 $0.00 0.00% 631,000 $0.10 $0.11 $0.10
02 May 2022 $0.10 $-0.01 -9.30% 40,600 $0.11 $0.11 $0.10
29 Apr 2022 $0.11 $0.00 0.00% 263,833 $0.11 $0.11 $0.11
28 Apr 2022 $0.11 $0.00 0.00% 86,281 $0.10 $0.11 $0.10
27 Apr 2022 $0.10 $0.00 0.00% 107,732 $0.11 $0.11 $0.10
26 Apr 2022 $0.11 $-0.01 -9.09% 370,023 $0.11 $0.11 $0.10
22 Apr 2022 $0.11 $0.01 9.52% 28,685 $0.11 $0.11 $0.11
21 Apr 2022 $0.11 $0.00 0.00% 181,563 $0.11 $0.11 $0.11
20 Apr 2022 $0.11 $0.00 0.00% 142,931 $0.11 $0.11 $0.10

Director Transactions Data provided by Morningstar.

Data provided by Morningstar.
Date Director Type Amount Value Notes
28 Mar 2022 Zlatko (Zack) Bozinovski Buy 185 $23,125
On-market trade.
25 Mar 2022 George Karafotias Buy 75 $9,750
On-market trade.
23 Mar 2022 Zheng (Kobe) Li Buy 300 $34,190
On-market trade.
21 Mar 2022 Zlatko (Zack) Bozinovski Buy 665 $75,500
On-market trade.
21 Mar 2022 George Karafotias Buy 213 $24,398
On-market trade.

Directors & Management Data provided by Morningstar.

Data provided by Morningstar.
Name Title Start Date Profile
Mr Eric Jiang Non-Executive Director Sep 2016
Mr Jiang has over 15 years' experience. Eric Jiang is an adviser to companies involved in trade between Australia and China. Eric brings a distinctive understanding of the cultural, economic and strategic context in which Australian businesses engage with China. He is chair of Remuneration and Nomination Committee, member of Audit and Risk Committee.
Mr George Karafotias Chief Financial OfficerExecutive Director Nov 2020
Mr Karafotias has held various roles in numerous public companies over the last 9 years and has previously provided corporate advisory services to listed and unlisted companies, focusing on restructuring and refinancing.
Mr Zheng (Kobe) Li Non-Executive DirectorCompany Secretary Jan 2019
Mr Li spent the previous 8 years with the Australian Securities Exchange (ASX) Listing Compliance team, as a Senior Advisor overseeing a portfolio of listed entities ensuring compliance with the ASX listing rules. During his tenure at the ASX he worked on many Initial Public Offerings (IPO's) and numerous complex corporate transactions. Kobe is a member of the Governance Institute of Australia.
Mr Zlatko (Zack) Bozinovski Chief Strategy OfficerExecutive Director Jul 2021
Mr Bozinovski has over 35 years' experience within FMCG and Pharmaceuticals companies in Australia and internationally. Mr Bozinovski co-founded Voost and has previously held senior positions at Uncle Tobys/Goodman Fielder, Pepsi Co and Sigma Pharmaceuticals.

Top Shareholders Data provided by Morningstar.

Data provided by Morningstar.
Name Shares Capital
Ggp Investments Pty Ltd (Ggp Superannuation Fund A/C) 104,556,688 32.51%
Wattle Trading Pty Ltd 40,390,823 12.56%
Monex Boom Securities (Hk) Ltd (Clients Account) 33,863,168 10.53%
Mr Xuan Khoa Pham 7,185,446 2.23%
Zlj Pty Ltd (The Bozinovski Family A/C) 4,350,000 1.35%
Jamata Pty Ltd + Llea Lk Pty Ltd (Lmb Wattle Trading Unit A/C) 3,623,635 1.13%
Brilliant River Limited 2,921,993 0.91%
Mr Andrew Grant 2,508,835 0.78%
Hsbc Custody Nominees (Australia) Limited 2,487,659 0.77%
Cw Retail Holdings Pty Ltd (Cw Retails Holdings A/C) 2,424,213 0.75%
Mr David James Stewart 2,286,543 0.71%
Cs Third Nominees Pty Limited (Hsbc Cust Nom Au Ltd 13 A/C) 1,980,529 0.62%
Eurofit S A Limited 1,712,379 0.53%
Gleneagle Asset Management Limited (Gleneagle Investmentfund A/C) 1,562,339 0.49%
Elzed Holdings Pty Ltd 1,500,000 0.47%
Citicorp Nominees Pty Limited 1,317,841 0.41%
Acee Group Pty Ltd 1,260,000 0.39%
Skandalellis Pty Ltd (Skanda Super Fund A/C) 1,074,212 0.33%
Mr Steven Ivak 1,000,000 0.31%
Cs Fourth Nominees Pty Limited (Hsbc Cust Nom Au Ltd 11 A/C) 1,000,000 0.31%

Profile

since

Note